Artículos (11) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E

    Bladder Cancer, Vol. 8, Núm. 4, pp. 379-393

  2. Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer

    Urologic Oncology: Seminars and Original Investigations, Vol. 40, Núm. 11, pp. 491.e11-491.e19

  3. Approach to Lower Urinary Tract Reconstruction: A Survey of Adult and Pediatric Urologist Perspectives and Experiences

    Frontiers in Urology, Vol. 2

  4. Comparison of surgical approaches to radical prostatectomy in our series beyond oncological and functional outcomes

    Actas Urologicas Espanolas, Vol. 46, Núm. 5, pp. 275-284

  5. Evidence-based Medicine: Perceptions, Attitudes, and Skills Among European Urology Residents

    European Urology Open Science, Vol. 45, pp. 44-49

  6. Evolution of renal function in patients with cT1 renal tumors after laparoscopic partial and radical nephrectomy. Predictive factors for renal function impairment

    Actas Urologicas Espanolas, Vol. 46, Núm. 2, pp. 63-69

  7. Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

    European Urology Open Science, Vol. 40, pp. 38-45

  8. Laparoscopic nephron sparing surgery and radical nephrectomy in cT1 renal tumors. Comparative analysis of complications and survival

    Actas Urologicas Espanolas, Vol. 46, Núm. 6, pp. 340-347

  9. Metastatic testicular cancer presenting with hematuria and flank pain

    Urology Annals, Vol. 14, Núm. 2, pp. 196-198

  10. Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center

    Urologic Oncology: Seminars and Original Investigations, Vol. 40, Núm. 7, pp. 345.e19-345.e23

  11. Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

    World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004